Inflammatory bowel diseases during the COVID-19 pandemic

Since the beginning of the COVID-19 pandemic in 2020, the safety of those with compromised immune systems and chronic disease has been of particular concern for health care providers. Inflammatory bowel diseases (IBD) are chronic, incurable conditions of digestive system with unknown aetiology, but...

Full description

Saved in:
Bibliographic Details
Main Authors: Edyta Derda, Edyta Szymańska, Magda Sokolek, Jarosław Kierkuś
Format: Article
Language:English
Published: Termedia Publishing House 2024-09-01
Series:Gastroenterology Review
Subjects:
Online Access:https://www.termedia.pl/Inflammatory-bowel-diseases-during-the-COVID-19-pandemic,41,54807,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since the beginning of the COVID-19 pandemic in 2020, the safety of those with compromised immune systems and chronic disease has been of particular concern for health care providers. Inflammatory bowel diseases (IBD) are chronic, incurable conditions of digestive system with unknown aetiology, but one of the causes is disordered immune response. Medical therapies most frequently used in IBD are immune suppressing or modifying with the rising use of biologic treatment. All these aspects make patients with Crohn’s disease and ulcerative colitis a group of particular risk. Therefore, the aim of this review is to discuss potential mechanisms, risks, and management of patients with IBD during COVID-19 pandemic.
ISSN:1895-5770
1897-4317